Login Register Cart 0
Generic placeholder image

Current Molecular Pharmacology

Editor-in-Chief

ISSN (Print): 1874-4672
ISSN (Online): 1874-4702

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Antiarrhythmic Potential of Epicardial Botulinum Toxin Injection for Suppression of Postoperative Atrial Fibrillation

Author(s): Michael Spartalis*, Eleftherios Spartalis, Dimitrios Iliopoulos and Gerasimos Siasos

Volume 17, 2024

Published on: 01 August, 2023

Article ID: e200623218118 Pages: 4

DOI: 10.2174/1874467217666230620114931

Price: $65

Abstract

Following heart surgery, postoperative atrial fibrillation (AF) is the most prevalent kind of secondary AF and the most frequent adverse event. Postoperative AF is related to a number of unfavorable cardiac outcomes, such as heart failure, stroke, and death. However, the pharmacological treatment for postoperative AF is only relatively efficient and is frequently linked to detrimental complications, including symptomatic bradycardia with atrioventricular block due to rate control drugs and elevated hemorrhage hazard attributable to the administration of anticoagulants. Ablation procedures also result in the irreversible damage of cardiac anatomic structures, which may have long-term negative implications on heart performance. As a result, there is an unmet demand for treatments that can minimize the incidence of postoperative AF in an effective and safe manner. Botulinum toxin is an established neurotoxin that has progressively gained use in every medical science domain. It hinders the propagation of impulses across nerve fibers without causing immediate damage to the cardiac tissue. The transient feature of botulinum toxin action and the eventual restoration of the autonomic nervous system transmission are undeniably advantageous and may render botulinum toxin a potential and feasible treatment approach for postoperative AF.

[1]
Cocco, A.; Albanese, A. Recent developments in clinical trials of botulinum neurotoxins. Toxicon, 2018, 147, 77-83.
[http://dx.doi.org/10.1016/j.toxicon.2017.08.014] [PMID: 28818530]
[2]
Tsuboi, M.; Furukawa, Y.; Kurogouchi, F.; Nakajima, K.; Hirose, M.; Chiba, S. Botulinum neurotoxin A blocks cholinergic ganglionic neurotransmission in the dog heart. Jpn. J. Pharmacol., 2002, 89(3), 249-254.
[http://dx.doi.org/10.1254/jjp.89.249] [PMID: 12184730]
[3]
Oh, S.; Choi, E.K.; Choi, Y.S. Short-term autonomic denervation of the atria using botulinum toxin. Korean Circ. J., 2010, 40(8), 387-390.
[http://dx.doi.org/10.4070/kcj.2010.40.8.387] [PMID: 20830252]
[4]
Oh, S.; Choi, E.K.; Zhang, Y.; Mazgalev, T.N. Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation. Circ. Arrhythm. Electrophysiol., 2011, 4(4), 560-565.
[http://dx.doi.org/10.1161/CIRCEP.111.961854] [PMID: 21659633]
[5]
Nizamieva, A.; Frolova, S.; Slotvitsky, M.; Kovalenko, S.; Tsvelaya, V.; Nikitina, A.; Sergeevichev, D.; Agladze, K. Cellular electrophysiological effects of botulinum toxin A on neonatal rat cardiomyocytes and on cardiomyocytes derived from human-induced pluripotent stem cells. Naunyn Schmiedebergs Arch. Pharmacol., 2023, 396(3), 513-524.
[http://dx.doi.org/10.1007/s00210-022-02332-1] [PMID: 36399184]
[6]
Saljic, A.; Hansen, M.E.H.; Dobrev, D. Botulinum toxin for prevention of post-operative atrial fibrillation. Naunyn Schmiedebergs Arch. Pharmacol., 2023, 396(3), 385-388.
[http://dx.doi.org/10.1007/s00210-023-02402-y] [PMID: 36715734]
[7]
Gaudino, M.; Di Franco, A.; Rong, L.Q.; Piccini, J.; Mack, M. Postoperative atrial fibrillation: From mechanisms to treatment. Eur. Heart J., 2023, 44(12), 1020-1039.
[http://dx.doi.org/10.1093/eurheartj/ehad019] [PMID: 36721960]
[8]
Hindricks, G.; Potpara, T.; Dagres, N.; Arbelo, E.; Bax, J.J.; Blomström-Lundqvist, C.; Boriani, G.; Castella, M.; Dan, G.A.; Dilaveris, P.E.; Fauchier, L.; Filippatos, G.; Kalman, J.M.; La Meir, M.; Lane, D.A.; Lebeau, J.P.; Lettino, M.; Lip, G.Y.H.; Pinto, F.J.; Thomas, G.N.; Valgimigli, M.; Van Gelder, I.C.; Van Putte, B.P.; Watkins, C.L.; Kirchhof, P.; Kühne, M.; Aboyans, V.; Ahlsson, A.; Balsam, P.; Bauersachs, J.; Benussi, S.; Brandes, A.; Braunschweig, F.; Camm, A.J.; Capodanno, D.; Casadei, B.; Conen, D.; Crijns, H.J.G.M.; Delgado, V.; Dobrev, D.; Drexel, H.; Eckardt, L.; Fitzsimons, D.; Folliguet, T.; Gale, C.P.; Gorenek, B.; Haeusler, K.G.; Heidbuchel, H.; Iung, B.; Katus, H.A.; Kotecha, D.; Landmesser, U.; Leclercq, C.; Lewis, B.S.; Mascherbauer, J.; Merino, J.L.; Merkely, B.; Mont, L.; Mueller, C.; Nagy, K.V.; Oldgren, J.; Pavlović, N.; Pedretti, R.F.E.; Petersen, S.E.; Piccini, J.P.; Popescu, B.A.; Pürerfellner, H.; Richter, D.J.; Roffi, M.; Rubboli, A.; Scherr, D.; Schnabel, R.B.; Simpson, I.A.; Shlyakhto, E.; Sinner, M.F.; Steffel, J.; Sousa-Uva, M.; Suwalski, P.; Svetlosak, M.; Touyz, R.M.; Dagres, N.; Arbelo, E.; Bax, J.J.; Blomström-Lundqvist, C.; Boriani, G.; Castella, M.; Dan, G-A.; Dilaveris, P.E.; Fauchier, L.; Filippatos, G.; Kalman, J.M.; La Meir, M.; Lane, D.A.; Lebeau, J-P.; Lettino, M.; Lip, G.Y.H.; Pinto, F.J.; Neil Thomas, G.; Valgimigli, M.; Van Gelder, I.C.; Watkins, C.L.; Delassi, T.; Sisakian, H.S.; Scherr, D.; Chasnoits, A.; Pauw, M.D.; Smajić, E.; Shalganov, T.; Avraamides, P.; Kautzner, J.; Gerdes, C.; Alaziz, A.A.; Kampus, P.; Raatikainen, P.; Boveda, S.; Papiashvili, G.; Eckardt, L.; Vassilikos, V.; Csanádi, Z.; Arnar, D.O.; Galvin, J.; Barsheshet, A.; Caldarola, P.; Rakisheva, A.; Bytyçi, I.; Kerimkulova, A.; Kalejs, O.; Njeim, M.; Puodziukynas, A.; Groben, L.; Sammut, M.A.; Grosu, A.; Boskovic, A.; Moustaghfir, A.; Groot, N.; Poposka, L.; Anfinsen, O-G.; Mitkowski, P.P.; Cavaco, D.M.; Siliste, C.; Mikhaylov, E.N.; Bertelli, L.; Kojic, D.; Hatala, R.; Fras, Z.; Arribas, F.; Juhlin, T.; Sticherling, C.; Abid, L.; Atar, I.; Sychov, O.; Bates, M.G.D.; Zakirov, N.U. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J., 2021, 42(5), 373-498.
[http://dx.doi.org/10.1093/eurheartj/ehaa612] [PMID: 32860505]
[9]
Kiaii, B.; Fox, S.; Chase, L.; Fernandes, M.; Stitt, L.W.; Guo, R.; Quantz, M.; Chu, M.W.; Koka, P.; McClure, R.S.; McKenzie, F.N.; Klein, G.J.; Novick, R.J.; Skanes, A.C. Postoperative atrial fibrillation is not pulmonary vein dependent: Results from a randomized trial. Heart Rhythm, 2015, 12(4), 699-705.
[http://dx.doi.org/10.1016/j.hrthm.2015.01.014] [PMID: 25595923]
[10]
Buckley, U.; Rajendran, P.S.; Shivkumar, K. Ganglionated plexus ablation for atrial fibrillation: Just because we can, does that mean we should? Heart Rhythm, 2017, 14(1), 133-134.
[http://dx.doi.org/10.1016/j.hrthm.2016.09.001] [PMID: 28007095]
[11]
Rostagno, C.; Blanzola, C.; Pinelli, F.; Rossi, A.; Carone, E.; Stefàno, P.L. Atrial fibrillation after isolated coronary surgery. Incidence, long term effects and relation with operative technique. Heart Lung Vessel., 2014, 6(3), 171-179.
[PMID: 25279359]
[12]
Pokushalov, E.; Kozlov, B.; Romanov, A.; Strelnikov, A.; Bayramova, S.; Sergeevichev, D.; Bogachev-Prokophiev, A.; Zheleznev, S.; Shipulin, V.; Salakhutdinov, N.; Lomivorotov, V.V.; Karaskov, A.; Po, S.S.; Steinberg, J.S. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: Results of a randomized pilot study. J. Am. Coll. Cardiol., 2014, 64(6), 628-629.
[http://dx.doi.org/10.1016/j.jacc.2014.04.062] [PMID: 25104535]
[13]
Waldron, N.H.; Cooter, M.; Haney, J.C.; Schroder, J.N.; Gaca, J.G.; Lin, S.S.; Sigurdsson, M.I.; Fudim, M.; Podgoreanu, M.V.; Stafford-Smith, M.; Milano, C.A.; Piccini, J.P.; Mathew, J.P. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm, 2019, 16(2), 178-184.
[http://dx.doi.org/10.1016/j.hrthm.2018.08.021] [PMID: 30414840]
[14]
Mitchell, L.B.; Exner, D.V.; Wyse, D.G.; Connolly, C.J.; Prystai, G.D.; Bayes, A.J.; Kidd, W.T.; Kieser, T.; Burgess, J.J.; Ferland, A.; MacAdams, C.L.; Maitland, A. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: A randomized controlled trial. JAMA, 2005, 294(24), 3093-3100.
[http://dx.doi.org/10.1001/jama.294.24.3093] [PMID: 16380589]
[15]
Romanov, A.; Pokushalov, E.; Ponomarev, D.; Bayramova, S.; Shabanov, V.; Losik, D.; Stenin, I.; Elesin, D.; Mikheenko, I.; Strelnikov, A.; Sergeevichev, D.; Kozlov, B.; Po, S.S.; Steinberg, J.S. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study. Heart Rhythm, 2019, 16(2), 172-177.
[http://dx.doi.org/10.1016/j.hrthm.2018.08.019] [PMID: 30414841]
[16]
Late-breaking science abstracts and featured science abstracts from the american heart association’s scientific sessions 2022 and late-breaking abstracts in resuscitation science from the resuscitation science symposium 2022. Circulation, 2022, 146(25), e569-e605.
[http://dx.doi.org/10.1161/CIR.0000000000001116] [PMID: 36534733]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy